Ethers are a class of organic compounds that contain an ether group—an oxygen atom connected to two alkyl or aryl groups. 38256-93-8, formula is C4H11NO, Name is 2-Methoxy-N-methylethanamine.They have the general formula R–O–R′, where R and R′ represent the alkyl or aryl groups. Computed Properties of 38256-93-8.
Pinto, Donald J. P.;Orwat, Michael J.;Smith, Leon M.;Quan, Mimi L.;Lam, Patrick Y. S.;Rossi, Karen A.;Apedo, Atsu;Bozarth, Jeffrey M.;Wu, Yiming;Zheng, Joanna J.;Xin, Baomin;Toussaint, Nathalie;Stetsko, Paul;Gudmundsson, Olafur;Maxwell, Brad;Crain, Earl J.;Wong, Pancras C.;Lou, Zhen;Harper, Timothy W.;Chacko, Silvi A.;Myers, Joseph E.;Sheriff, Steven;Zhang, Huiping;Hou, Xiaoping;Mathur, Arvind;Seiffert, Dietmar A.;Wexler, Ruth R.;Luettgen, Joseph M.;Ewing, William R. research published 《 Discovery of a Parenteral Small Molecule Coagulation Factor XIa Inhibitor Clinical Candidate (BMS-962212)》, the research content is summarized as follows. Factor XIa (FXIa) is a blood coagulation enzyme that is involved in the amplification of thrombin generation. Mounting evidence suggests that direct inhibition of FXIa can block pathol. thrombus formation while preserving normal hemostasis. Preclin. studies using a variety of approaches to reduce FXIa activity, including direct inhibitors of FXIa, have demonstrated good antithrombotic efficacy without increasing bleeding. Based on this potential, the authors targeted the efforts at identifying potent inhibitors of FXIa with a focus on discovering an acute antithrombotic agent for use in a hospital setting. Herein the authors describe the discovery of a potent FXIa clin. candidate, I (FXIa Ki = 0.7 nM), with excellent preclin. efficacy in thrombosis models and aqueous solubility suitable for i.v. administration. BMS-962212 is a reversible, direct, and highly selective small mol. inhibitor of FXIa.
Computed Properties of 38256-93-8, 2-Methoxy-N-methylethanamine is a useful research compound. Its molecular formula is C4H11NO and its molecular weight is 89.14 g/mol. The purity is usually 95%.
2-Methoxy-N-methylethanamine is a drug that binds to the cannabinoid receptor CB1. It has been shown to be effective in the treatment of cardiac arrhythmia and may also be used as an anti-inflammatory drug. 2MEMEA has been shown to have pharmacokinetic properties that are different from those of other amines, which may be due to its ability to form hydrogen bonds with water molecules. 2MEMEA also has diversified effects on some types of cancer cells, including hyperproliferative and amine-dependent cancers., 38256-93-8.
Referemce:
Ether – Wikipedia,
Ether | (C2H5)2O – PubChem